InMed Pharmaceuticals
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has InMed Pharmaceuticals's balance sheet done over the years? Its assets were worth $11,822,782 last year, which is less than in the previous period. 22% of InMed Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $2,616,673, which means an increase by 30% compared compared to last year.
Debt to Assets
| 2015 | 1338017 | 62.50K | 4.67% |
|---|---|---|---|
| 2016 | 1216745 | 456.16K | 37.49% |
| 2017 | 6409645 | 284.24K | 4.43% |
| 2018 | 21333493 | 712.88K | 3.34% |
| 2019 | 15073785 | 1.19M | 7.9% |
| 2020 | 7500459 | 1.92M | 25.6% |
| 2021 | 9781216 | 2.40M | 24.58% |
| 2022 | 12787580 | 3.70M | 29.01% |
| 2023 | 14106340 | 2.01M | 14.3% |
| 2024 | 11822782 | 2.61M | 22.13% |
INM Balance Sheet (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 6.57M | 8.91M | 6.17M | 7.36M | 5.79M | 9.80M | 18.34M | 5.15M | 41.92K | 134.18K |
Short term investments | 43.06M | 44.42M | 44.80K | 46.46K | 42.29K | 3.93M | 1.78M | 0 | 0 | 0 |
Net receivables | 352.83K | 260.39K | 88.02K | 11.91K | 45.24K | 64.73K | 40.57K | 0 | 65.79K | 0 |
Inventory | 1.24M | 1.61M | 2.49M | -955.80M | -919 | -1.49K | -4 | 2 | 0 | 1 |
Other current assets | 477.74K | -8.94B | 797.22K | 956.76M | 418.92K | 324.67K | 154.68K | 273.07K | 37.33K | 74.48K |
Total current assets | 8.68M | 11.33M | 9.59M | 8.37M | 6.29M | 14.12M | 20.32M | 5.33M | 145.05K | 202.03K |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 1.24M | 723.42K | 904.25K | 326.59K | 402.59K | 42.52K | 42.36K | 20.79K | 3.65K | 5.09K |
Goodwill | 0 | 0 | 2.02M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 1.78M | 1.94M | 2.10M | 1.06M | 799.26K | 902.43K | 968.23K | 1.04M | 1.06M | 1.13M |
Long term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current assets | 100K | 104.90K | 176.63K | 14.65K | 0 | 1 | 0 | 0 | 0 | 0 |
Total non-current assets | 3.13M | 2.77M | 3.18M | 1.40M | 1.20M | 944.96K | 1.01M | 1.07M | 1.07M | 1.13M |
Total assets | 11.82M | 14.10M | 12.78M | 9.78M | 7.50M | 15.07M | 21.33M | 6.40M | 1.21M | 1.33M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | -1.99B | 0 | 0 | -959.15K | 0 | 0 | 0 | 0 | 0 |
Short term debt | 317.79K | 375.71K | 404.27K | 80.48K | 68.81K | 0 | 0 | 0 | 0 | 0 |
Total current liabilities | 1.97M | 2.00M | 3.31M | 2.21M | 1.67M | 1.19M | 712.88K | 284.24K | 456.16K | 62.50K |
| Non-current liabilities: | ||||||||||
Long term debt | 644.86K | 15.99K | 389.49K | 189.28K | 247.46K | 0 | 0 | 0 | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 236.70K | 0 |
Total non-current liabilities | 644.86K | 15.99K | 389.49K | 189.28K | 247.46K | 0 | 0 | 284.24K | 236.70K | 57.92K |
Total liabilities | 2.61M | 2.01M | 3.70M | 2.40M | 1.92M | 1.19M | 712.88K | 284.24K | 456.16K | 62.50K |
| Data source | Data source | Data source | Data source |